Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

L.A. McKeown

December 06, 2022

News Daily News

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

L.A. McKeown

May 05, 2022

News Daily News

FDA Safety Communication Updates Stance on Endologix AAA Grafts

L.A. McKeown

January 13, 2022

News Industry News

Cardiologs Unveils New Solution to Enable Use of Smartwatches for Remote Patient Monitoring

July 21, 2021

News Daily News

CMS Releases Proposed Updates for Coverage of Transcatheter MV Repair

Todd Neale

July 01, 2020

News Conference News

ACC, EHRA Cancel 2020 Meetings Over COVID-19

Michael O'Riordan

March 09, 2020

News Daily News

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

Todd Neale

November 20, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Daily News

FDA: New Concerns Surface With Endologix Grafts for AAA

L.A. McKeown

October 28, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Daily News

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

L.A. McKeown

March 15, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

Shelley Wood

November 30, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2017

Shelley Wood

April 28, 2017

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

Advertisement

Evoque and Patisiran: A Tale of Two Regulatory Journeys

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

FDA Safety Communication Updates Stance on Endologix AAA Grafts

Cardiologs Unveils New Solution to Enable Use of Smartwatches for Remote Patient Monitoring

CMS Releases Proposed Updates for Coverage of Transcatheter MV Repair

ACC, EHRA Cancel 2020 Meetings Over COVID-19

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

FDA: New Concerns Surface With Endologix Grafts for AAA

FDA Expands TAVR Indication to Low-Risk Patients

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

TCTMD’s Top 10 Most Popular Stories for November 2018

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

TCTMD’s Top 10 Most Popular Stories for August 2018

TCTMD’s Top 10 Most Popular Stories for October 2017

TCTMD’s Top 10 Most Popular Stories for May 2017

TCTMD’s Top 10 Most Popular Stories for April 2017

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content